Europeiska unionen - isländska - EMA (European Medicines Agency)

pfizer europe ma eeig - lorlatinib - krabbamein, lungnakrabbamein - antineoplastic agents, protein kinase inhibitors - lorviqua as monotherapy is indicated for the treatment of adult patients with anaplastic lymphoma kinase (alk)‑positive advanced non‑small cell lung cancer (nsclc) previously not treated with an alk inhibitor. lorviqua as monotherapy is indicated for the treatment of adult patients with alk‑positive advanced nsclc whose disease has progressed after:alectinib or ceritinib as the first alk tyrosine kinase inhibitor (tki) therapy; orcrizotinib and at least one other alk tki.

Island - isländska - LYFJASTOFNUN (Icelandic Medicines Agency)

zentiva k.s.* - etoricoxibum inn - filmuhúðuð tafla - 30 mg

Island - isländska - LYFJASTOFNUN (Icelandic Medicines Agency)

actavis group ptc ehf. - oxycodonum hýdróklóríð - forðatafla - 20 mg

Island - isländska - LYFJASTOFNUN (Icelandic Medicines Agency)

williams & halls ehf - etoricoxibum inn - filmuhúðuð tafla - 30 mg

Island - isländska - LYFJASTOFNUN (Icelandic Medicines Agency)

actavis group ptc ehf. - diazepamum inn - tafla - 5 mg

Island - isländska - LYFJASTOFNUN (Icelandic Medicines Agency)

williams & halls ehf - etoricoxibum inn - filmuhúðuð tafla - 120 mg

Island - isländska - LYFJASTOFNUN (Icelandic Medicines Agency)

actavis group ptc ehf. - diazepamum inn - tafla - 2 mg

Island - isländska - LYFJASTOFNUN (Icelandic Medicines Agency)

actavis group ptc ehf. - diazepamum inn - endaþarmslausn - 5 mg/2,5 ml

Island - isländska - LYFJASTOFNUN (Icelandic Medicines Agency)

actavis group ptc ehf. - diazepamum inn - endaþarmslausn - 10 mg/2,5 ml

Island - isländska - LYFJASTOFNUN (Icelandic Medicines Agency)

zentiva k.s.* - etoricoxibum inn - filmuhúðuð tafla - 60 mg